Therapy Related Myeloid Neoplasms Following PARP Inhibitors : Real-Life Experience - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2022

Therapy Related Myeloid Neoplasms Following PARP Inhibitors : Real-Life Experience

Celine Berthon
  • Function : Author
Jacques Vargaftig
  • Function : Author
Géraldine Salmeron
  • Function : Author
Nadine Morineau
  • Function : Author
Felix Blanc-Durand
  • Function : Author
Patricia Pautier
  • Function : Author
Veronique Vergé
  • Function : Author
Nathalie Auger
  • Function : Author
Myrtille Thomas
  • Function : Author
Laetitia Stefani
  • Function : Author
Marion Lepelley
  • Function : Author
Sylvain Thepot
  • Function : Author
Marie-Pierre Gourin
  • Function : Author
Pascal Bourquard
  • Function : Author
Matthieu Duchmann
  • Function : Author
Pierre Morice
  • Function : Author
Mauricette Michallet
  • Function : Author
Lionel Ades
  • Function : Author
Pierre Fenaux
  • Function : Author
Christian Recher
  • Function : Author
Hervé Dombret
  • Function : Author
Arnaud Pages
  • Function : Author
Christophe Marzac
  • Function : Author
Alexandra Leary
  • Function : Author
Jean-Baptiste Micol
  • Function : Author

Dates and versions

hal-04031847 , version 1 (16-03-2023)

Identifiers

Cite

Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, et al.. Therapy Related Myeloid Neoplasms Following PARP Inhibitors : Real-Life Experience. Blood, 2022, 140 (Supplement 1), pp.12335-12338. ⟨10.1182/blood-2022-163478⟩. ⟨hal-04031847⟩
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More